IL6 and atherosclerosis: Prior studies indicate that celastrol significantly reduces inflammation by inhibiting pro-inflammatory cytokines, such as IL-6, while also mitigating the harmful effects of oxidized low-density lipoprotein (oxLDL), both of which are crucial in the pathogenesis of atherosclerosis [33].